List of Field Safety Notices from 14 to 18 July 2025.
Similar Posts
Good clinical practice for clinical trials
How to show the MHRA you’re meeting good clinical practice (GCP) standards and what to expect from an inspection.
Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma, EL(25)A/38
LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing.
Consultation on Medical Devices Regulations: Routes to market and in vitro diagnostic devices
The MHRA is inviting members of the public to provide their views on proposed changes to the regulatory framework for medical devices.
Dr Nicola Rose: A new antibiotic is positive news – but it will take more to stay ahead of superbugs
The MHRA’s Interim Executive Director of Science and Research writes in The British Medical Journal on the approval of the UK’s first new UTI antibiotic in nearly 30 years, and the wider challenge of tackling antibiotic resistance.
NHS red tape blitz delivers game-changing new cancer treatment
Patients to benefit from new era in cancer treatment, as Government slashes red tape to unleash life-saving innovation
MHRA approves UK’s first anti-PD-1 monoclonal antibody for treatment of aggressive form of lung cancer
As with all products, we will keep its safety under close review